E. J. Kim has served as Chief Executive Officer of Theracion Biomedical since establishment of the company in June 2016. Mr. Kim has more than 20 years of experience in the medical device and pharmaceutical industry. Prior to establishing Theracion biomedical, he served as principal scientist at one of the major nonvascular stent/medical device company from 2010 to 2016. Before 2010, Mr. Kim worked for Celltrion Chemical Institute, Korea, which is currently Celltrion Pharm., one of the leading pharmaceutical manufacturers in Korea, serving as senior scientist for drug delivery system. Prior to joining Celltrion, he spent three years at Kwangdong Pharmaceuticals, Korea, in R&D center for studying various OTC/ETC and DDS, and 5 years at Samyang Biopharm., Korea, working in new medical technology and pharmaceuticals, such as the drug delivery system (DDS), and anticancer drugs, and biodegradable guided tissue regeneration membrane. Throughout his carrier, he has experienced R&D, RA and clinical trials in the field of medical device and pharmaceuticals.

Mr. Kim participated in graduate school of Chemical engineering, McMaster University, CANADA and received an Ph.D. in biomaterials from the department of polymer science and engineering at Kyungpook National University, Korea.